|1.||Kinoshita, Tomomi: 2 articles (03/2009 - 10/2007)|
|2.||Huang, Linfang: 2 articles (03/2009 - 10/2007)|
|3.||Toyoshima, Megumi: 2 articles (03/2009 - 10/2007)|
|4.||Harada, Kouji: 2 articles (03/2009 - 10/2007)|
|5.||Koizumi, Akio: 2 articles (03/2009 - 10/2007)|
|6.||Asakawa, Akihiro: 2 articles (03/2009 - 10/2007)|
|7.||Inoue, Kayoko: 2 articles (03/2009 - 10/2007)|
|8.||Chen, Shilin: 1 article (03/2009)|
01/01/1995 - "The present results suggest that hypophagia and inhibitions of respiratory rate are attributable to the direct action of OOS-TMP on the central nervous system, while other symptoms are associated with lung injury."
12/01/1988 - "The morphogenesis of pulmonary injury induced by OOS-TMP was studied in mice by light and transmission electron microscopy. "
12/01/1988 - "Morphogenesis of O,O,S-trimethyl phosphorothioate-induced pulmonary injury in mice."
08/01/1985 - "Cellular responses to O,O,S-trimethyl phosphorothioate-induced pulmonary injury in rats."
10/01/1985 - "These data, early elevation of PAM esterase levels with a concomitant increase in cytotoxic activity and decreased TIC and CIC in bronchopulmonary lavage fluid, support the view that pathogenesis of OOS-TMP produced lung injury could be due to increased protease levels."
01/01/1993 - "In contrast, pair-fed (to 20 mg/kg rats) rats (n = 4) did not become hypothermic, negating any role of hypophagia in OOS-TMP associated hypothermia. "
01/01/1993 - "O,O,S-Trimethyl phosphorothioate induces hypothermia in Fischer 344 rats in a manner dependent on both doses and housing temperatures."
01/01/1993 - "for Fischer 344 female rats was found to be 11.8 mg/kg. OOS-TMP induced long-lasting (more than 48 h) and extensive hypothermia at doses > or = 14 mg/kg at a typical laboratory temperature (22 degrees C) while it produced typical symptoms at 10 mg/kg without hypothermia. "
01/01/1995 - "Oral administration of OOS-TMP at 20 mg/kg induced marked hypophagia, progressive weight loss and hypothermia. "
01/01/1995 - "On the other hand, by this route of administration, OOS-TMP at 20 mg/kg failed to induce hypothermia, hypercapnia and lung injury. "
|4.||Body Weight (Weight, Body)
12/01/1986 - "In contrast, interleukin-2 production was elevated by 24 h following treatment, but had returned to control levels by day 7. These data suggest that OOS-TMP was able to block the generation of cytotoxic T lymphocytes and antibody responses at doses of OOS-TMP that did not affect body weight or splenic lymphocyte number and this suppression was reversible."
05/01/1989 - "Animals received either corn oil or a corn oil solution of OOS-TMP at a dose of 40 mg/kg body weight by gavage and were studied at the following time intervals after treatment: 10 days, 30 days, 90 days, 6 months, and 1 year. "
12/01/1986 - "However, the mitogenic response of splenocytes from animals treated with nontoxic doses of OOS-TMP (as measured by body weight loss, serum cholinesterase levels and splenic lymphocyte number) to concanavalin A was not significantly suppressed, but the response to the B cell mitogen lipopolysaccharide was slightly decreased on day 1 following treatment. "
|2.||Nitric Oxide Synthase (NO Synthase)
|4.||L-Lactate Dehydrogenase (Lactate Dehydrogenase)
|5.||NG-Nitroarginine Methyl Ester (L-NAME)
|6.||Protease Inhibitors (Protease Inhibitor)